- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Renalytix AI (RNLXY)
Renalytix AI stock price live, this page displays OTC RNLXY stock exchange data. View the RNLXY premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Renalytix AI real time stock price chart below.
What Is the Renalytix AI Stock Price Today?
The Renalytix AI stock price today is 0.1800.
What Is the Stock Symbol for Renalytix AI?
The stock symbol for Renalytix AI is ""RNLXY.""
What Stock Exchange Does Renalytix AI Trade On?
Renalytix AI is listed and trades on the OTC Markets stock exchange.
Is Renalytix AI a Good Stock to Buy?
Determining whether Renalytix AI—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the RNLXY quote. (ISIN: US75973T1016)
What Is the Renalytix AI Stock Price Today?
The Renalytix AI stock price today is 0.1800.
What Is the Stock Symbol for Renalytix AI?
The stock symbol for Renalytix AI is ""RNLXY.""
What Stock Exchange Does Renalytix AI Trade On?
Renalytix AI is listed and trades on the OTC Markets stock exchange.
Is Renalytix AI a Good Stock to Buy?
Determining whether Renalytix AI—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the RNLXY quote. (ISIN: US75973T1016)
0.1800
0.0000(0.00%)
Closed·
Fair Value
An estimate of a Renalytix AI Nas's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.1800
0.1850
52 wk Range
0.1200
0.4200
RNLXY Scorecard
Full Analysis
Analysts anticipate sales growth in the current year
RNLXY is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a Renalytix AI Nas's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.18000.1850
52 wk Range
0.12000.4200
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
RNLXY Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Renalytix AI Nas's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Renalytix AI Company Profile
Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for clinical management kidney diseases in the United States. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics, and personalized patient data from electronic health record systems to generate a unique patient risk score. Its products are used in kidney disease diagnosis and prognosis, clinical care, patient stratification for drug clinical trials, and drug target discovery. It has a license agreement with Mount Sinai Health System to develop and commercialize licensed products in connection with the application of artificial intelligence for the diagnosis of kidney disease; and partnership agreement with Atrium Health, Wake Forest Baptist Health, and Wake Forest School of Medicine to implement an advanced clinical care model to improve kidney health and reduce kidney disease progression and kidney failure. The company was formerly known as Renalytix AI plc and changed its name to Renalytix Plc in June 2021. The company was incorporated in 2018 and is based in New York, New York.
Compare RNLXY to Peers and Sector
Metrics to compare | RNLXY | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipRNLXYPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.2x | −0.7x | −0.5x | |
PEG Ratio | −0.02 | 0.02 | 0.00 | |
Price/Book | −24.1x | 1.6x | 2.6x | |
Price / LTM Sales | 11.4x | 1.5x | 3.3x | |
Upside (Analyst Target) | - | 25.8% | 43.5% | |
Fair Value Upside | Unlock | 6.6% | 6.3% | Unlock |
Earnings
Latest Release
Jun 17, 2025
EPS / Forecast
-- / -0.03
Revenue / Forecast
-- / 1.20M
People Also Watch
FAQ
What Stock Exchange Does Renalytix AI Nas Trade On?
Renalytix AI Nas is listed and trades on the OTC Markets stock exchange.
What Is the Stock Symbol for Renalytix AI Nas?
The stock symbol for Renalytix AI Nas is "RNLXY."
What Is the Renalytix AI Nas Market Cap?
As of today, Renalytix AI Nas market cap is 33.04M.
What Is Renalytix AI Nas's Earnings Per Share (TTM)?
The Renalytix AI Nas EPS (TTM) is -0.22.
When Is the Next Renalytix AI Nas Earnings Date?
Renalytix AI Nas will release its next earnings report on 03 Nov 2025.
From a Technical Analysis Perspective, Is RNLXY a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Renalytix AI Nas Stock Split?
Renalytix AI Nas has split 0 times.
How Many Employees Does Renalytix AI Nas Have?
Renalytix AI Nas has 102 employees.
What is the current trading status of Renalytix AI Nas (RNLXY)?
As of 05 Aug 2025, Renalytix AI Nas (RNLXY) is trading at a price of 0.18, with a previous close of 0.18. The stock has fluctuated within a day range of 0.18 to 0.19, while its 52-week range spans from 0.12 to 0.42.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.